Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS: ENZN · Delayed Price · USD
0.170
0.00 (0.00%)
Jul 3, 2024, 9:30 AM EDT - Market closed
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $12.62 million as of July 3, 2024. Its market cap has decreased by -76.42% in one year.
Market Cap
12.62M
Enterprise Value
-33.37M
1-Year Change
-76.42%
Ranking
n/a
Category
Stock Price
$0.17
Market Cap Chart
Since December 1, 1998, Enzon Pharmaceuticals's market cap has decreased from $405.00M to $12.62M, a decrease of -96.88%. That is a compound annual growth rate of -18.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2016 | 20.30M | -32.33% |
| Dec 31, 2015 | 30.00M | -37.63% |
| Dec 31, 2014 | 48.10M | -5.87% |
| Dec 31, 2013 | 51.10M | -74.03% |
| Dec 31, 2012 | 196.80M | -39.17% |
| Dec 30, 2011 | 323.50M | -55.48% |
| Dec 31, 2010 | 726.60M | 51.82% |
| Dec 31, 2009 | 478.60M | 82.60% |
| Dec 31, 2008 | 262.10M | -37.73% |
| Dec 31, 2007 | 420.90M | 12.66% |
| Dec 29, 2006 | 373.60M | 13.83% |
| Dec 30, 2005 | 328.20M | -45.37% |
| Dec 31, 2004 | 600.80M | 15.34% |
| Dec 31, 2003 | 520.90M | -27.55% |
| Dec 31, 2002 | 719.00M | -70.12% |
| Dec 31, 2001 | 2.41B | -6.51% |
| Dec 29, 2000 | 2.57B | 61.21% |
| Dec 31, 1999 | 1.60B | 238.74% |
| Dec 31, 1998 | 471.40M | 16.40% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |